IO Biotech, Inc. (IOBTQ) Cash from Financing Activities (2021 - 2025)

IO Biotech (IOBTQ) has 3 years of Cash from Financing Activities data on file, last reported at $21.3 million in Q3 2025.

• Quarterly Cash from Financing Activities changed N/A year-over-year to $21.3 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $32.8 million (up 327670.0% YoY) and the FY2023 annual result came in at $71.9 million, changed N/A from the prior year.
• Cash from Financing Activities grew to $21.3 million in Q3 2025, from $11.5 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $187.5 million in Q4 2021 to a low of -$10000.0 in Q4 2023.
• A 3-year average of $59.6 million and a median of $43.3 million in 2021 frame the typical range for Cash from Financing Activities.